je.st
news
Ablynx agrees Merck cancer deal worth up to 1.7 billion euros
2014-02-04 08:05:11| Biotech - Topix.net
Belgian biotech company Ablynx has signed a deal with Merck & Co worth up to 1.7 billion euros to develop ways of triggering the body to fight cancer by itself.
Tags: deal
worth
cancer
euros
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||